chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from healthcare professional on 14 December 2012. A 02-year-old male patient, who had no known allergies, no illness at time of vaccination with no medical conditions, had received a intramuscular dose of FLUZONE dose last year. On 14 December 2012, the patient had red and hot area on bilateral joints (ankle, knee, elbow, toe joints), quarter sized area on the back of right leg was red and had red area on the left arm. Corrective treatment and relevant laboratory tests were not reported. At the time of this report, the patient had not recovered from the events. Documents held by sender: None. Follow-up information received from a healthcare professional on 03 May 2013. It was reported that the patient had received first dose of FLUZONE vaccine on an unspecified date in 2011. The patient had no illness at the time of vaccination and the patient had not received any vaccine within 4 weeks of FLUZONE vaccine. The patients birth weight reported as 5lb and 7oz. The patient has 1 twin brother. On 14 December 2012 the CBC was done with manual differential was ordered results were consistent with viral illness, however still undetermined if the viral illness caused the red and hot joints (ankles, knees, elbows and toe joints) additional labs were ordered C-reactive protein, SED rate were mildly elevated ASO titer was negative. The patient was instructed to take ZYRTEC 5 mg daily. On 29 April 2013 symptoms were fully resolved without any complications.
This spontaneous report was received from a health professional refers to an unspecified number of patients of unknown demographics. Pertinent medical history, concurrent conditions and drug reactions/allergies were not reported. On unspecified dates, the patients were administered with doses of VAQTA (lot # L004743, expiry date: 01-JUN-2017; lot # L001445, expiry date: 15-FEB-2016) which was exposed to temperatures outside of the recommended range. Concomitant medications were not reported. No adverse experience was reported. This is one of the six reports received from the same source (MARRS # 1506USA014028, 1506USA011037, 1506USA014024, 1506USA014025 and 1506USA014026). Additional information is not expected as the reporter did not wish further contact.
Stomach cramps, nausea and extreme diarrhea until March 29 (12 days).
Acute urinary retention: Underwent cystourethroscopy, Foley catheter placement Small bowel obstruction: resolved with bowel rest, NG decompression. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
I just don't know if this from the vaccine or if they hit a nerve; She is in a bit of a panic; I have had some numbness, more like how it feels when it your blood pressure taken and thing pumps up around your arm and the rest of the arm feels numb.; This is a spontaneous report from a contactable consumer (patient herself). A 61-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration, in left arm on an unspecified date (age at vaccination: 61-years) as dose 1, single for covid-19 immunisation. Patient had her second dose of vaccination today (unspecified date). Patients medical history and concomitant medications were not reported. On 10Mar2021, she had some numbness, more like how it feels when it your blood pressure taken and thing pumps up around your arm and the rest of the arm feels numb. She thought the numbness had to do with where they injected the vaccine, maybe they hit a nerve. It was a strange numbness where the injection was, the numbness went down near her wrist. It felt like a strange pulsing type of thing. Like how they pumped up her arm, and the cuff got tighter. It was a little different than numbing feeling. She clarified that the numbness started from her injection site to her wrist, and it had been the same momentary thing all together. It was stronger up by her injection site. She did not put it down, she did not do the little whatever on the scan. She has had a symptom and thought it would go away by now. She was wondering. She was due to receive her second dose of the covid vaccine today. She was wondering if she should get her second dose of the covid vaccine in her other arm. She had a little bit of time to complete a report with safety. She had to leave soon. She did not have her patient record card with her at that time. While on the call, she was trying to send an email out to other teachers. She went to send it to 38 other teachers and it did not save. Now she had to start all the way over. She was in a bit of a panic on an unspecified date. She really just wanted to know if she should get the second dose of the covid vaccine in the same arm. If this is a reaction of the vaccine, she does not want to get the second dose of the covid vaccine in her other arm, and then have both arms tingling. The outcome of event for numbness of upper extremities was not recovered and for panic reaction it was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patchy reddened swollen warm area about 3"X2.5" located on Left arm about 5 inches below injection site.  No fever or arthralgia.  Used Benadryl without effect initially.  Used ice and Ibuprofen which were helpful. Saw HCP. On 4/15 pm she described the beginning of hives starting in the scalp and moving downward on the body. She took Benadryl and it stopped the hives at the waist.  On 4/16, the arm area has moved upward toward the injection site and has enlarged to approx. 6" in diameter but is less swollen, hot and painful.  She continues with Benadryl or Zyrtec and Ibuprofen. She also called her HCP after the hives started.
Pt took vaccine on Thursday evening (12/28), on Friday, after Lunch felt some what flushed and abdominal pain, then in evening vomiting and diarrhea, temp 102F.  This for approximately 12 hours.  Better on Saturday am, cont with abdominal symptoms for several days.  Now improved.
Patient received second dose (2/19) too early from dose #1 #1  2/5/2022 #2 2/19/2022
First couple days after vaccine she experienced severe body aches and then on 3/23/21 the injection site starting itching around 3:00pm and around 6:00pm and she noticed it was swollen, very hot and red.  She applied cool rag on it that night and then she woke up on the 3/24/21 and the raised area had raised bubbles on it and it was oozing clear fluid.  This lasted 3/24/21 and started drying up 3/25/21.  No pain at injection site.
Right shoulder in which I received PPSV vaccine began to ache, stiffen.  Went to bed around 11 pm, with shoulder pain, couldn't get comfortable in any position, severe muscle spasms began about 11:30 pm and continued until around 2:30 am.
arm stayed sore and swollen, as well as underarm and armpit; arm stayed sore and swollen, as well as underarm and armpit; arm stayed sore and swollen, as well as underarm and armpit; arm stayed sore and swollen, as well as underarm and armpit; patient received third (booster) dose of BNT162B2; patient received BNT162B2 and influenza vaccine on the same day; patient received BNT162B2 and influenza vaccine on the same day; This is a spontaneous report from a non-contactable consumer (patient). A 71-year-old female patient received the third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Fe3590), via an unspecified route of administration in the left arm, on 23Oct2021 12:00 (at the age of 71-years-old) as a single dose for COVID-19 immunization and influenza vaccine (MANUFACTURER UNKNOWN), via an unspecified route of administration in the right arm, on 23Oct2021 as a single dose for immunisation. Medical history included penicillin allergy. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no concomitant medications. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL9262), in the left arm, on 11Feb2021 (at the age of 70-years-old) for COVID-19 immunisation and the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN6198), in the left arm, on 05Mar2021 (at the age of 70-years-old) for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced arm stayed sore and swollen, as well as underarm and armpit on 23Oct2021 20:00. Additionally, the patient received BNT162B2 and influenza vaccine on the same day on 23Oct2021 and patient received third (booster) dose of BNT162B2 on 23Oct2021 at 12:00. The clinical course was reported as follows: Right after the booster, the patient iced the arm as she did for the first two vaccines. This time the arm stayed sore and swollen, as well as the underarm and armpit. She took paracetamol (TYLENOL EXTRA STRENGTH) 3 times a day for 3 days, then just at bedtime for 2 days. Therapeutic measures were taken as of arm stayed sore and swollen, as well as underarm and armpit as aforementioned. The clinical outcome of arm stayed sore and swollen, as well as underarm and armpit was recovered on an unspecified date and of patient received BNT162B2 and influenza vaccine on the same day and patient received third (booster) dose of BNT162B2 was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow up attempts are possible. No further information is expected.
Approximately 19 hours after my second Pfizer vaccine, I experienced dizziness, plus fever and chills.  I experienced two bouts of extreme dizziness, within minutes of each other.  I did not go to the hospital nor did I call 911.  My husband helped me to my bed where I went to bed and slept off and on for over two hours. I felt well enough to eat lunch, then went back to bed, where I slept for three hours.  No more episodes of dizziness occurred.
PT STARTED TO HAVE WHAT LOOKED LIKE A VASO VAGAL RESPONSE. HE STARTED TO LEAN BACK FURTHER ON HIS CAR AND LOOKED LIKE HE WAS HAVING A SEIZURE. HE HAD SOMEONE ELSE WITH HIM  AT THE PHARMACY WAITING OUTSIDE. I CALLED HER TO THE VACCINE ROOM. I CALLED EMS IMMEDIATELY AND HE LOST CONSCIOUSNESS WHILE I WAS ON THE PHONE FOR 5 MINUTES OR SO. HE REGAINED CONSCIOUSNESS WHILE I WAS ON THE PHONE WITH EMS. PARAMEDICS ARRIVED AND THEY DID VITALS AND HE WAS CLEARED TO GO
diffuse recurrent urticaria, w/o any other apparent cause (no infectious site) starting 10 days p/vax & still lasting 30 days later;
swollen lymph nodes on her right armpit and at the base of her neck, like above her collar bone, on the right side; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes on her right armpit and at the base of her neck, like above her collar bone, on the right side) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes on her right armpit and at the base of her neck, like above her collar bone, on the right side). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes on her right armpit and at the base of her neck, like above her collar bone, on the right side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product us was reported No treatment information was provided
expire powder of Menveo (expiration date July 2020); This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 2-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA175A, expiry date 31st July 2020) for prophylaxis.   On 6th May 2021, the patient received Menveo. On 6th May 2021, unknown after receiving Menveo, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The patient had taken an expired powder of Menveo and liquid portion was not expired which led to expired vaccine used. The reporter had limited information about lot numbers and expiration date on the vials and was not sure if accurate information was provided. The reported batch number AMVA1758 did not exist and was updated to AMVA175A as per sales data sheet review. The reporter did not consented to follow up.
Numbness, in fingers and toe, within days progress to numbness, pain, tingling in hands, feet, back, face, and throat, continued to get progressively worse, unable to walk independently. 11-18-2016 - Diagnosis - GBS Treatment - IVIG.
Chills, low fever, achey muscles, achey joints, fatigue, headache,
Patient recieved 2nd dose of Covid19 vaccine on 06/25/21. The next day patient stated they felt nauseous and experienced vomiting. Two days after administration patient began to experience swelling and hives on their. Pharmacist recommended an antihistamine/topical steroid and MD if sx ongoing.
Patient called complaining of redness that started at ZOSTAVAX inj. site (back of left arm). Started approx. size of penny day of inj. On day 3 pt. says redness is size of silver dollar & complains of generally not feeling well. Instructed pt to see MD. Pt did not want to go today. Wants to follow up Tues.
Moderna COVID-19 Vaccine EUA.  Received 2nd dose on 1/28/21 approx. 10:30 a.m.  Approx. 13:30 p.m. ears began feeling warm, left shoulder more painful to touch than first injection, and body slightly sluggish. Left work approx. 17:00, upon arrival home wife noticed my ears were red and I felt very warm. Digital temperature of forehead was 102.7, and ears were 106.4.  Took digital B/P and it was 185 / 85. Took two Aleve tabs and sat down to rest. One hour later took temps again and forehead was 100.4 and ears were 102.4. Still felt drained. Removed some clothing, took shower and to sleep. 02:00 a.m. awoke, temps within normal range. Next morning B/P normal as well 135 / 56.
2 weeks after the vaccination, developed vertigo on and off, ear fluid, dizziness, nausea, lightheadedness that is still ongoing
There are no side effects. You r'e  info said I missed my appointment, I did not. My Wife and I were there and received our Second Shot to complete our Vaccination. When We got to the staging area, your people could not find our reservation, even though we showed them your paperwork. So they put us in as a Walk-in. \ Once again, We  should up, and received our Vaccination.
Headache, Myalgia, Arthralgia, CHILLS Narrative: Employee was sent home from work
Whole thigh red, hot and swollen for more than a week with hard nodule at injection site.
Pins and needles throughout entire body on and off from 15 min after vaccine until 18 hours after vaccine. High fatigue 1-2 days after vaccine. Low grade nausea on and off 0-3 days after vaccine.
Info has been received from a physician's assistant concerning a female who was vaccinated with pneumococcal vaccine 23 polyvalent. Subsequently, 4 weeks later, the pt's titers were checked and the pt's response was "minimal." The pt sought unspecified medical attention. Additional info has been requested.
Symptoms - extreme muscle and joint pain and burning, and headache  for about 10 hours. 102 fever for about 2 hours followed by stomach pain, diarrhea and dry heaves for about 3 hours.  Fatigue for 24 hours afterward.
The pt experienced a "large tight knot" at the site. The pt was seen by her physician. The are from the deltoid to mid humerus with induration, erythema that blanches to pressure and pain. The diagnosis was possible cellulitis. The pt's physician prescribed Cefzil for seven days and ice to the area for two to three days. The next day improvement was noted. Upon internal review induration,erythema and possible cellulitis was determined to be "other medical events". Additional information has been requested.
Pt received influenza vaccine and pneumococcal vaccine on 9/14/09. Presents to clinic 3/4/10 c/o left arm pain since received the vaccines. Pt evaluated + Lt AC joint pain w/exam but c/o mid-humerus pain at times.
No additional AE reported; PROQUAD was administered to 1 patient following a temperature excursion; This spontaneous report was received from a consumer and referred to a patient of unknown age and gender. The patient's medical history, concurrent condition, and concomitant therapy were not reported.  On 02-DEC-2022, the patient received measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection (valid lot# W019630 with reported expiry date 19-DEC-2023)(strength, dose description, and route of administration were not provided) for prophylaxis after a temperature excursion with temperature 27.9 Fahrenheit (F) and time frame was 1 hour and 35 minutes (Incorrect product storage). There was no previous temperature excursion. There was no additional adverse event (No adverse event). And there was no additional information provided.
4 days following flu vax pt admitted to hosp w/dehydration; devel low grade temp, malaise, dec appetite, disoriented; slowly improving; On many other meds MD feels pt had some encephalopathy;
Wild dream which caused me to awaken.  Wild brain activity with images, lights and sounds flashing for approximately 15 minutes, felt like my brain was trembling.  Subsided but left me exhausted for 24 hours following.
Hives, throughout, injection site arm & neck, w/o resp. distress OTC BENADRYL
Information was received from a licensed practical nurse regarding a male patient of unknown age, who on 28-OCT-2014, was vaccinated with a dose of M-M-R II (lot # J014873, expiration date 21-NOV-2015) that was improperly stored (dosage and route of administration not provided). No adverse effect reported. No further information was available. This is one of seven reports from the same reporter. Additional information has been requested.
Narrative:  Received 2nd vaccine dose Monday 2/22/21, started with swelling/angioedema on Wed 2/24/21 into Thurs 2/25/21 for which he presented to ED, swelling somewhat improved with ED interventions, patient admitted for observation. Takes lisinopril also which has been discontinued.
Pt vaccinated with Pneumovax 23 developed stiff neck, very severe arthritic pain & a temp 101.  In-depth med hx rec'd.  Dx = pneumonia.  SEE WORM
2nd dose is overdue; A spontaneous report was received from a patient of an unknown age who received Moderna's COVID-19 Vaccine (mRNA-1273) and 2nd dose of Moderna vaccine was overdue.   The patient's medical history was not provided.     The patient reported recently moved to an area where they just started giving 1st dose of Moderna whereas mine 2nd dose was overdue.  The date for when the patient received their first of two planned doses of mRNA-1273 (Batch number: not given) intramuscularly for prophylaxis of COVID-19 infection was not provided.    Treatment information was not provided.    Action taken with mRNA-1273 in response to the event was not provided.  The event was considered resolved on an unknown date.; Reporter's Comments: This report refers to a case of inappropriate schedule of product administration for mRNA-1273.  There were no reported adverse events associated with this case.
This spontaneous report was received from a store employee refers to an approximately 83 year old male patient. No medical history was reported. On 25-MAR-2015 the patient was vaccinated with ZOSTAVAX, dose: 1 ml (route not provided). Concomitant therapies included VALTREX, omeprazole (manufacturer unknown) and prednisone (manufacturer unknown). On 25-MAR-2015 incorrect dose administered was reported as the patient received 1ml dose of the vaccine. On 29-MAR-2015, the patient experienced loss of hearing in his left ear (medically significant). The reporter was informed that the patient sought medical attention and had an office visit to unspecified physician. The outcome of the event and medication error was unknown. The causality assessment was not provided. No product quality issue was involved. Upon internal review the deafness unilateral was considered as medically significant. Additional information is not expected. The reporter cannot be contacted.
VERTIGO; CAN NOT OPEN JAW; BODY ACHE; FEELING REALLY TIRED; LACK OF FOCUS; EYE DISORDER; EAR DISORDER; This spontaneous report received from a parent concerned a 45 year old male. The patient's height, and weight were not reported. The patient's past medical history included defibrillator, and concurrent conditions included muscular dystrophy, atrial fibrillation, and cardio myopathy. The patient experienced drug allergy when treated with fentanyl, and meclozine.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced lack of focus. On APR-2021, the subject experienced eye disorder. On APR-2021, the subject experienced ear disorder. On 01-APR-2021, the subject experienced body ache. On 01-APR-2021, the subject experienced feeling really tired. On 02-APR-2021, the subject experienced vertigo. On 02-APR-2021, the subject experienced can not open jaw. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, and feeling really tired on 04-APR-2021, was recovering from can not open jaw, had not recovered from vertigo, and the outcome of lack of focus, eye disorder and ear disorder was not reported. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
pt recvd vax 8NOV95 1145AM when mom dropped pt @ grandmothers, states pt cried non-stop until mom picked her up;pt given APAP for fever of 100.4;also choking & coughing during night;seen by MD next day & treated accordingly
16APR97 230PM vax given;17APR97 2PM site red, warm to touch-MD ordered cool cloth to site;t100.7;18APR97 930AM red, warm, soft @ site-compress tx-t99.4;3PM office visit-local rxn;19APR back red-itching;30APR chest also;dx allergy to vax
Had gotten my shot on Friday morning and didn't really have any side effects until Sunday morning.  Had nausea, headache and chills
Unclear if coincidental or directly related to vaccine - macular rash evaluated 3-22-12, onset 3-18-12. Also with (+) Mono, (+)  Lyme antibodies.
From initial information received on 10/06/03 from a health care professional regarding an adverse event occurring in the U.S.A., it was reported that a female patient (age and birth date not reported) received Fluzone SV '200-'2004 USP, lot number U1260AA, administered intra-muscularly (route and site not reported) on 10/03/03. The following day, the patient developed pain, edema, redness, and itching at injection site, as well as fever, achiness, and pain and swelling in her joints. The patient's recovery status was not reported. The reporter of this case is the same reporter of cases 200302253, 200302255, 200302256, and 200302258.